Urinary Tissue Inhibitor of Metalloproteinase-2 As an Early Predictor for Acute Kidney Injury in Critically Ill Children

Overview

Journal Int J Health Sci (Qassim)

Specialty General Medicine

Date 2023 Jul 7

PMID 37416842

Authors

Maha A Abouhadid

Tarek A Abdel Gawad

Howida H El Gebaly

Azza A Abdallah

Amira S El Refay

Neveen M Helmy

Ahmad M Allam

Affiliations

Soon will be listed here.

Abstract

Objectives: Acute kidney injury (AKI) is one of the most devastating complications of critical illness in children. Serum creatinine (Scr) is considered the gold standard for AKI diagnosis yet noted to be late and inaccurate. This raises the need for an early and accurate biochemical parameter for the early detection of AKI. This research aimed to explore the role of urinary tissue inhibitor metalloproteinase 2 (TIMP-2) in the early prediction of AKI, compared to standard biomarkers, in critically ill children admitted to pediatric intensive care unit (PICU). Urine TIMP2 was previously explored in multiple adult studies and showed promising results; however, the study of its role in pediatric population was limited.

Methods: This study was a prospective cohort study including 42 critically ill children who are at increased risk of AKI. Cases were recruited from the PICU in the Children's Hospital of Ain-Shams University, Cairo - Egypt over 10 months' duration. Urine samples were collected to measure urinary TIMP-2 and blood samples were taken to measure the levels of Scr, creatinine clearance, and blood urea nitrogen. Urine output in 24 h was also calculated.

Results: Urinary TIMP-2 showed considerably higher levels in AKI compared to non-AKI patients as early as day 1, whereas increased levels of Scr and decreased urine output were noticed later (day 3 and day 5, respectively). A notable correlation existed between TIMP-2 at day 1 and creatinine at day 3.

Conclusion: The present study revealed that urinary TIMP-2 could have an important role in the early prediction of AKI before the increase in Scr and more deterioration in kidney functions.

Citing Articles

Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) as a Prognostic Biomarker in Acute Kidney Injury: A Narrative Review.

Delrue C, Speeckaert M Diagnostics (Basel). 2024; 14(13).

PMID: 39001241 PMC: 11241058. DOI: 10.3390/diagnostics14131350.

Protective effects of N-acetylcysteine and S-adenosyl-Lmethionine against nephrotoxicity and immunotoxicity induced by ochratoxin A in rats.

Alkhattabi N, Khalifa F, Al Doghaither H, Al-Ghafari A, Tarbiah N, Sabban A Int J Health Sci (Qassim). 2024; 18(2):17-24.

PMID: 38455596 PMC: 10915916.

References

Askenazi D, Ambalavanan N, Goldstein S . Acute kidney injury in critically ill newborns: what do we know? What do we need to learn?. Pediatr Nephrol. 2008; 24(2):265-74. PMC: 2755786. DOI: 10.1007/s00467-008-1060-2. View

Yamashita T, Doi K, Hamasaki Y, Matsubara T, Ishii T, Yahagi N . Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study. Crit Care. 2014; 18(6):716. PMC: 4300076. DOI: 10.1186/s13054-014-0716-5. View

Bell M, Larsson A, Venge P, Bellomo R, Martensson J . Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury. Dis Markers. 2015; 2015:158658. PMC: 4381987. DOI: 10.1155/2015/158658. View

de Mendonca A, Vincent J, Suter P, Moreno R, Dearden N, Antonelli M . Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000; 26(7):915-21. DOI: 10.1007/s001340051281. View

Huang C, Shih C, Chung K, Kao K, Wu H . Predictive value of plasma neutrophil gelatinase-associated lipocalin for acute renal failure in patients with severe sepsis. J Chin Med Assoc. 2016; 79(8):428-34. DOI: 10.1016/j.jcma.2016.03.006. View

Koyner J, Shaw A, Chawla L, Hoste E, Bihorac A, Kashani K . Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI. J Am Soc Nephrol. 2014; 26(7):1747-54. PMC: 4483589. DOI: 10.1681/ASN.2014060556. View

Goldstein B, Giroir B, Randolph A . International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6(1):2-8. DOI: 10.1097/01.PCC.0000149131.72248.E6. View

Maizel J, Daubin D, Vong L, Titeca-Beauport D, Wetzstein M, Kontar L . Urinary TIMP2 and IGFBP7 Identifies High Risk Patients of Short-Term Progression from Mild and Moderate to Severe Acute Kidney Injury during Septic Shock: A Prospective Cohort Study. Dis Markers. 2019; 2019:3471215. PMC: 6466900. DOI: 10.1155/2019/3471215. View

Pajenda S, Ilhan-Mutlu A, Preusser M, Roka S, Druml W, Wagner L . NephroCheck data compared to serum creatinine in various clinical settings. BMC Nephrol. 2015; 16:206. PMC: 4674950. DOI: 10.1186/s12882-015-0203-5. View

10.

Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw S, Bell M . Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013; 17(1):R25. PMC: 4057242. DOI: 10.1186/cc12503. View

11.

Esmeijer K, Schoe A, Ruhaak L, Hoogeveen E, Soonawala D, Romijn F . The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery. Sci Rep. 2021; 11(1):1071. PMC: 7806984. DOI: 10.1038/s41598-020-80196-2. View

12.

Bihorac A, Chawla L, Shaw A, Al-Khafaji A, Davison D, Demuth G . Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med. 2014; 189(8):932-9. DOI: 10.1164/rccm.201401-0077OC. View

13.

Ferrari F, Romero-Gonzalez G, Topete L, Senzolo M, Lorenzin A, Husain-Syed F . Routine Adoption of Urinary [IGFBP7]∙[TIMP-2] to Assess Acute Kidney Injury at Any Stage 12 hours After Intensive Care Unit Admission: a Prospective Cohort Study. Sci Rep. 2019; 9(1):16484. PMC: 6848119. DOI: 10.1038/s41598-019-52790-6. View

14.

Gocze I, Koch M, Renner P, Zeman F, Graf B, Dahlke M . Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS One. 2015; 10(3):e0120863. PMC: 4370650. DOI: 10.1371/journal.pone.0120863. View

15.

Cuartero M, Ballus J, Sabater J, Perez X, Nin N, Ordonez-LLanos J . Cell-cycle arrest biomarkers in urine to predict acute kidney injury in septic and non-septic critically ill patients. Ann Intensive Care. 2017; 7(1):92. PMC: 5589717. DOI: 10.1186/s13613-017-0317-y. View

16.

Xie Y, Ankawi G, Yang B, Garzotto F, Passannante A, Breglia A . Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury. Kidney Int. 2019; 95(6):1486-1493. DOI: 10.1016/j.kint.2019.01.020. View

17.

Westhoff J, Tonshoff B, Waldherr S, Poschl J, Teufel U, Westhoff T . Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury. PLoS One. 2015; 10(11):e0143628. PMC: 4659607. DOI: 10.1371/journal.pone.0143628. View

18.

Sakyi S, Ephraim R, Adoba P, Amoani B, Buckman T, Mantey R . Tissue inhibitor metalloproteinase 2 (TIMP-2) and insulin-like growth factor binding protein 7 (IGFBP7) best predicts the development of acute kidney injury. Heliyon. 2021; 7(9):e07960. PMC: 8436126. DOI: 10.1016/j.heliyon.2021.e07960. View

19.

Meersch M, Schmidt C, Van Aken H, Martens S, Rossaint J, Singbartl K . Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014; 9(3):e93460. PMC: 3968141. DOI: 10.1371/journal.pone.0093460. View

20.

Andreoli S . Acute kidney injury in children. Pediatr Nephrol. 2008; 24(2):253-63. PMC: 2756346. DOI: 10.1007/s00467-008-1074-9. View